| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |